Latest Posts
About This Stock
More About This Stock
Read
Read
Read
NanoAntibiotics CEO Says His Firm Is Poised For Growth In Biotech's Potent Liver Disease Treatment Space
Morning Call For January 20, 2016
Article By:
Jim Van Meerten
Wednesday, January 20, 2016 8:58 AM EDT
March E-mini S&Ps (ESH16 -1.82%) are down -1.84% at a 4-3/4 month low and European stocks are down -3.20% at a 15-month low as a -3.06% plunge in crude oil (CLG16 -3.72%) to a fresh 12-year low drags down energy producers.
Synthetic Biologics Announces Positive Phase 2 In Irritable Bowel Syndrome
Article By:
Terry Chrisomalis
Wednesday, December 9, 2015 7:15 AM EDT
Synthetic Biologics announced that they had obtained positive phase 2 results in a phase 2 trial in patients with Irritable Bowel Syndrome -- IBS.
In this article: SYN